⌘K

Home/Filings/4/0001209191-16-133879

4//SEC Filing

REVA Medical, Inc. 4

Accession 0001209191-16-133879

CIK 0001496268operating

View on SEC.gov Company Profile

Filed

Jul 24, 8:00 PM ET

Accepted

Jul 25, 7:32 PM ET

Size

8.1 KB

Accession

0001209191-16-133879

Insider Transaction Report

Form 4

Period: 2016-07-21

REVA Medical, Inc.RVA:AX

Director

Transactions

Award
Common Stock
2016-07-21+6,300→ 21,300 total
Award
Stock Option (Right to Buy)
2016-07-21+11,800→ 11,800 total
Exercise: $8.90Exp: 2026-07-21→ Common Stock (11,800 underlying)

Holdings

Common Stock
(indirect: Stratford GEM PTY Ltd.)
18,606.1

Footnotes (3)

[F1]These restricted stock units will vest in full on the earlier of (i) May 25, 2017 or (ii) one day prior to the Issuer's 2017 Annual General Meeting of Stockholders.
[F2]Represents shares held by Stratford GEM PTY Ltd. Anne Keating is the sole director of Stratford GEM PTY Ltd. and controls the voting rights with respect to the shares held by Stratford GEM PTY Ltd. Ms. Keating disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein.
[F3]Twenty-five (25%) of the option shares vest on August 25, 2016, with the remaining option shares vesting in three (3) equal quarterly installments thereafter.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

REVA Medical, Inc.

CIK 0001496268

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001496268

Filing Metadata

Form type: 4
Filed: Jul 24, 8:00 PM ET
Accepted: Jul 25, 7:32 PM ET
Size: 8.1 KB

View on SEC.gov